About Culmination Bio
Culmination Bio is a Healthcare company based in St. George (United States) founded in 2022. Novel therapeutics are developed and clinical data services are provided. Culmination Bio has raised $10 million across 1 funding round from investors including Amgen and Merck Global Health Innovation Fund. The company has 1 employees. Culmination Bio offers products and services including Culmination Intelligence Platform and Novel Clinical Insights. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Siteless CRO. Its legal entity is CULMINATION, INC. Its competitors include Litmus Health, Avacare and Center Point Clinical Services.
Company details
Culmination Bio was established in 2022 and is headquartered in St. George, United States. Operations center on the biotechnology sector, where novel therapeutics for various applications are advanced through development stages. Clinical data services are also managed, supporting research and trial processes for pharmaceutical partners. The companys domain, culmination.com, facilitates access to these specialized offerings in the therapeutics and data management fields.
- Headquarters St. George, United States
- Employees 1
- SectorsHealthcare
- Website culmination.com
- Social LinkedIn X
- Legal Name Culmination, Inc.
- Total Equity Funding$10M (USD)
in 1 rounds
- Latest Funding Round$10M (USD), Series A
Nov 2023
- InvestorsAmgen
& 1 more
- Employee Count1
Products & Services of Culmination Bio
Culmination Bio offers a comprehensive portfolio of products and services, including Culmination Intelligence Platform and Novel Clinical Insights.
Provides clinical data and biospecimens for research and health insights.
Generates insights from multi-modal data for therapeutic development.
Funding Insights of Culmination Bio
Culmination Bio has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 1
- Last Round Series A — $10M
- First Round $10M
(Nov 2023)
- Investors Count 2
All 1 funding rounds of Culmination Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2023 | $10M | Series A | – | Merck Global Health Innovation Fund |
2 investors in total: 2 institutional.
Investors in Culmination Bio
Culmination Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen and Merck Global Health Innovation Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital is focused on the life science sector. | merckghifund.com | Kenilworth, United States | ||
Developer of pharmaceutical products for treating multiple diseases | 1980 | amgen.com | Thousand Oaks, United States |
Investor details for Culmination Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Culmination Bio
9 people are tracked at Culmination Bio (4 in leadership, 5 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Michael Wiley | Chief Operating Officer | Leadership |
Nate Stevens | Director Of Operations | Leadership |
Lincoln Nadauld | Chief Executive Officer | Leadership |
Casey Frankenberger | Svp, Head Of Data | Leadership |
Amanda Cole | Office Manager | Team |
Joshua Fuller | Manager, Commercial Implementation | Team |
Megan Phelps | Commercial Implementation Manager | Team |
Jared Evans | Senior Bioinformatician | Team |
Harry Hayter | Svp, Business Development | Team |
Complete people profiles for Culmination Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Culmination Bio
2 dated milestones of Culmination Bio across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Culmination Bio is founded.
- Funding First funding round of $10.0M.
Competitors of Culmination Bio
Culmination Bio has 3 listed competitors in our database. They include Litmus Health, Avacare and Center Point Clinical Services.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| litmushealth.com | 2014 | Austin, United States | Data from wearables is leveraged for clinical trial decisions. | |||
| avacare.com | 2002 | Danbury, United States | 1 | Provides clinical trial management services for sponsors, sites, and patients globally. | ||
| centerpointclinicalservices.com | 2013 | Malvern, United States | Offers siteless CRO and pharmacist-led solutions for clinical trials management. |
Detailed competitors of Culmination Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Culmination Bio
The website of Culmination Bio (culmination.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 29.2% vs previous month
Websites whose visitors overlap most with Culmination Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Culmination Bio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Culmination Bio
Complete news archive for Culmination Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Culmination Bio
Culmination Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Culmination Bio is headquartered in St. George, United States. It is registered at St. George, Utah, United States.
Culmination Bio is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Nov 2023.
Culmination Bio has 1 employees.
Culmination Bio was established in 2022 and is headquartered in St. George, United States. Operations center on the biotechnology sector, where novel therapeutics for various applications are advanced through development stages. Clinical data services are also managed, supporting research and trial processes for pharmaceutical partners. The companys domain, culmination.com, facilitates access to these specialized offerings in the therapeutics and data management fields.
Culmination Bio's top competitors include Litmus Health, Avacare and Center Point Clinical Services.
Culmination Bio offers Culmination Intelligence Platform and Novel Clinical Insights.
Culmination Bio has 2 investors. Key investors include Amgen, and Merck Global Health Innovation Fund.
Culmination Bio operates through Culmination, Inc..